These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 18571904

  • 21. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
    Jeong CW, Lim DJ, Son H, Lee SE, Jeong H.
    Urol Int; 2008; 80(2):157-61. PubMed ID: 18362485
    [Abstract] [Full Text] [Related]

  • 22. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF, Goa KL.
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [Abstract] [Full Text] [Related]

  • 23. [Re-examination of the criteria for clinical evaluation on bacterial prostatitis--analysis of the data of the clinical study of temafloxacin].
    Arakawa S, Kamidono S, Hirose T, Kumamoto Y, Suzuki K, Ito Y, Ban Y, Kawada Y, Kumon H, Ohmori H.
    Hinyokika Kiyo; 1994 May; 40(5):455-66. PubMed ID: 8023771
    [Abstract] [Full Text] [Related]

  • 24. An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia.
    Lin TY, Lin SM, Chen HC, Wang CJ, Wang YM, Chang ML, Wang CH, Liu CY, Lin HC, Yu CT, Hsieh LL, Kuo HP, Huang CD.
    Chang Gung Med J; 2007 May; 30(4):321-32. PubMed ID: 17939262
    [Abstract] [Full Text] [Related]

  • 25. Treatment of chronic bacterial prostatitis with amikacin through anal submucosal injection.
    Hu WL, Zhong SZ, He HX.
    Asian J Androl; 2002 Sep; 4(3):163-7. PubMed ID: 12364969
    [Abstract] [Full Text] [Related]

  • 26. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
    Abelson MB, Heller W, Shapiro AM, Si E, Hsu P, Bowman LM, AzaSite Clinical Study Group.
    Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
    [Abstract] [Full Text] [Related]

  • 27. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K, Reshedko G, Orasan R, Sanchez M, Teras J, Babinchak T, Dukart G, Cooper A, Dartois N, Gandjini H, Orrico R, Ellis-Grosse E, 309 Study Group.
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [Abstract] [Full Text] [Related]

  • 28. [Clinical studies on chronic prostatitis and prostatitis-like syndrome. (3). Clinical re-examination of chronic bacterial prostatitis using the criteria for clinical evaluation].
    Ikeuchi T.
    Hinyokika Kiyo; 1990 May; 36(5):561-8. PubMed ID: 2399857
    [Abstract] [Full Text] [Related]

  • 29. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C, Jasovich A, Teglia O, Oliva ME, Lentnek A, de Wouters L, Zlocowski JC, Dukart G, Cooper A, Mallick R, 308 Study Group.
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [Abstract] [Full Text] [Related]

  • 30. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
    Chen Y, Yang H, Lu G, Wu X, Huang W, Wu Y, Lv X, Wu G, Zhang G, Li Q, Sun Y.
    Chemotherapy; 2012 Jan; 58(3):249-56. PubMed ID: 22890091
    [Abstract] [Full Text] [Related]

  • 31. On chronic prostatitis with special studies of Staphylococcus epidermidis.
    Wedrén H.
    Scand J Urol Nephrol Suppl; 1989 Jan; 123():1-36. PubMed ID: 2483757
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
    Magri V, Perletti G, Cai T, Stamatiou K, Trinchieri A, Montanari E.
    Chemotherapy; 2019 Jan; 64(1):8-16. PubMed ID: 31112957
    [Abstract] [Full Text] [Related]

  • 37. Antimicrobial therapy for chronic bacterial prostatitis.
    Perletti G, Marras E, Wagenlehner FM, Magri V.
    Cochrane Database Syst Rev; 2013 Aug 12; 2013(8):CD009071. PubMed ID: 23934982
    [Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients.
    Zhang ZC, Jin FS, Liu DM, Shen ZJ, Sun YH, Guo YL.
    Asian J Androl; 2012 Nov 12; 14(6):870-4. PubMed ID: 22864282
    [Abstract] [Full Text] [Related]

  • 39. [Clinical study of levofloxacin (DR-3355) on uro-genital infections--with special reference to usefulness for chronic prostatitis].
    Suzuki K, Horiba M.
    Hinyokika Kiyo; 1992 Jun 12; 38(6):737-43. PubMed ID: 1632334
    [Abstract] [Full Text] [Related]

  • 40. [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
    Gehanno P, Pessey JJ, Serrano E.
    Med Mal Infect; 2005 Jun 12; 35(6):335-43. PubMed ID: 16023320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.